Physician profile
Anup Vora
NPI 1992951586
$58,003.63
in general payments reported to CMS, 2019-2025
64 companies · $5,296 in 2025
The $5,296 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $1,342 · 2021: $2,955 · 2022: $1,884 · 2023: $4,674 · 2024: $6,540 · 2025: $5,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,507 · Food and Beverage: $7,398 · Travel and Lodging: $1,323 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,506.66 |
| Food and Beverage | $7,398.35 |
| Travel and Lodging | $1,323.00 |
| Education | $282.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $33,696.93 | 2019-2024 | Rezum Generator, Tactra, Ams 700 |
| Johnson & Johnson Health Care Systems INC. | $4,200.00 | 2024 | |
| Janssen Global Services, LLC | $2,600.00 | 2025 | |
| Myriad Genetic Laboratories, INC. | $2,185.54 | 2020-2025 | Prolaris |
| Sn Holdings, LLC | $2,030.00 | 2023 | |
| Astellas Pharma US INC | $1,724.39 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Teleflex LLC | $779.55 | 2021-2024 | Urolift |
| Becton, Dickinson and Company | $706.66 | 2025 | |
| Janssen Biotech, INC. | $702.16 | 2019-2025 | Erleada, Akeega |
| Neotract INC. | $697.94 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $596.22 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $579.10 | 2023-2025 | Gemtesa, Orgovyx |
| Allergan, INC. | $565.29 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $550.94 | 2022-2025 | Pylarify |
| Abbvie INC. | $488.36 | 2019-2025 | Botox, Lupron Depot |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $470.88 | 2019-2024 | Edex, Xiaflex, Aveed |
| Urovant Sciences INC | $460.42 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $373.56 | 2019-2025 | Provenge |
| Tempus Ai, INC | $328.19 | 2024-2025 | Xt Cdx |
| Ferring Pharmaceuticals INC. | $314.52 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $307.22 | 2019-2025 | |
| Medtronic, INC. | $295.74 | 2022-2025 | Interstim |
| Merck Sharp & Dohme LLC | $290.75 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Olympus America INC. | $232.54 | 2023-2024 | Itind System |
| Antares Pharma, INC. | $222.98 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $208.28 | 2019-2025 | Speedicath |
| Urogen Pharma, INC. | $196.31 | 2022-2025 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $175.00 | 2022 | |
| Endo USA, INC. | $168.97 | 2024-2025 | Xiaflex, Aveed, Edex |
| Immunitybio, INC. | $158.44 | 2025 | |
| Myovant Sciences INC. | $139.80 | 2021-2022 | |
| Tolmar, INC. | $139.59 | 2024-2025 | Eligard, Jatenzo |
| Tolmar Pharmaceuticals, INC. | $126.70 | 2019-2022 | |
| Amgen INC. | $110.44 | 2019-2024 | Evenity, Prolia |
| Blue Earth Diagnostics | $109.61 | 2019-2023 | |
| Bioprotect Medical, INC. | $104.42 | 2024-2025 | Bioprotect Balloon Implant System |
| Janssen Pharmaceuticals, INC | $83.95 | 2025 | Erleada |
| Angiodynamics, INC. | $80.59 | 2023 | Nanoknife |
| Lantheus Medical Imaging, INC. | $80.05 | 2024 | |
| Accord Healthcare, INC. | $79.96 | 2023-2024 | |
| Axonics, INC. | $71.29 | 2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $66.92 | 2025 | |
| Acerus Pharmaceuticals Corporation | $50.69 | 2020-2022 | |
| Ambu INC. | $49.51 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $39.29 | 2020 | |
| Clarus Therapeutics INC. | $34.71 | 2021 | |
| Travere Therapeutics, INC. | $32.33 | 2019 | |
| Foundation Medicine, INC. | $27.41 | 2021-2022 | |
| Therapeuticsmd, INC. | $24.22 | 2019 | |
| Davol INC. | $20.95 | 2023 | Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals LP | $20.93 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $20.80 | 2019 | |
| Palette Life Sciences, INC. | $20.06 | 2022 | |
| Procept Biorobotics Corporation | $19.36 | 2023 | Aquabeam Robotic System |
| Hollister Incorporated | $18.89 | 2023 | Infyna Chic, Vapro |
| Azurity Pharmaceuticals, INC. | $18.54 | 2025 | Azmiro |
| Genzyme Corporation | $18.13 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.20 | 2024 | Givlaari |
| Verity Pharmaceuticals INC. | $16.77 | 2025 | Trelstar |
| Abc Home Medical Supply, INC. | $16.09 | 2024 | |
| Profound Medical Corp. | $14.22 | 2025 | Tulsa-Pro |
| Currax Pharmaceuticals LLC | $11.77 | 2020 | |
| Laborie Medical Technologies Corp. | $11.56 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anup Vora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.